Lexicon Pharmaceuticals | LXRX - Trade Creditors

Stock Price
1.84
Daily Change
-0.03 -1.60%
Monthly
12.20%
Yearly
220.00%
Q2 Forecast
1.83

Lexicon Pharmaceuticals reported $3.08M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Abbott USD 4.24B 117M Dec/2025
Acadia Pharmaceuticals USD 10.9M 10.84M Dec/2025
Agios Pharmaceuticals USD 18.36M 1.2M Dec/2025
Akebia Therapeutics USD 21.18M 11.1M Dec/2025
Alnylam Pharmaceuticals USD 115.72M 1.87M Dec/2025
AstraZeneca USD 25.28B 252M Dec/2025
BioMarin Pharmaceutical USD 759.03M 39.41M Dec/2025
Coherus Biosciences USD 9.91M 14.98M Dec/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Esperion Therapeutics USD 65.07M 12.44M Dec/2025
Halozyme Therapeutics USD 20.9M 5.54M Dec/2025
Illumina USD 240M 22M Dec/2025
Insmed USD 79.91M 316K Dec/2025
Ironwood Pharmaceuticals USD 1.61M 224K Sep/2025
J&J USD 11.99B 2.37B Dec/2025
Lexicon Pharmaceuticals USD 3.08M 714K Dec/2025
MacroGenics USD 4.79M 1.15M Dec/2025
MannKind USD 9.03M 1.76M Dec/2025
Merck USD 4.15B 102M Sep/2025
Moderna USD 317M 50M Dec/2025
Novartis USD 4.46B 99M Dec/2025
PTC Therapeutics USD 45.49M 8.87M Dec/2025
Puma Biotechnology USD 6.39M 962K Sep/2025
Sarepta Therapeutics USD 280.84M 186.83M Dec/2025
Thermo Fisher Scientific USD 3.62B 502M Dec/2025
Ultragenyx Pharmaceutical USD 40.57M 6.33M Sep/2025
United Therapeutics USD 7.1M 460.9M Dec/2025
Vanda Pharmaceuticals USD 39.09M 33.28M Dec/2024